ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
57.12
-0.62 (-1.07%)
After Hours: 57.12 0.00 (0.00%)
Feb 11, 4:35PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 56.17 - 57.57
52 week 48.99 - 75.33
Open 56.73
Vol / Avg. 1.45M/1.42M
Mkt cap 8.08B
P/E 23.25
Div/yield 0.30/2.10
EPS 2.46
Shares 140.04M
Beta 0.69
Inst. own 63%
Apr 21, 2016
Q3 2016 ResMed Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jan 21, 2016
Q2 2016 ResMed Inc Earnings Call
Jan 21, 2016
Q2 2016 ResMed Inc Earnings Release
Jan 13, 2016
ResMed Inc at JPMorgan Healthcare Conference
Dec 2, 2015
ResMed Inc at Piper Jaffray Healthcare Conference
Nov 19, 2015
ResMed Inc Annual Shareholders Meeting (Estimated)
Nov 19, 2015
ResMed Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 19.91% 21.02%
Operating margin 23.76% 24.38%
EBITD margin - 28.73%
Return on average assets 16.16% 15.53%
Return on average equity 24.33% 21.10%
Employees 4,340 -
CDP Score - -

Address

9001 Spectrum Center Blvd
SAN DIEGO, CA 92123-1438
United States - Map
+1-858-7462400 (Phone)
+1-858-8365501 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.

Officers and directors

Robert D. Douglas President, Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Michael J. Farrell Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Don Darkin President – innovation & operations
Age: 62
Bio & Compensation  - Reuters
Jim Hollingshead Ph.D. President - Americas
Age: 52
Bio & Compensation  - Reuters
Anne Reiser President – Europe & Asia Pacific
Age: 54
Bio & Compensation  - Reuters
David Brian Pendarvis J.D. Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 56
Bio & Compensation  - Reuters
Agnes Lee Senior Director - Investor Relations
Bio & Compensation  - Reuters
Peter C. Farrell Ph.D. Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Ronald R. Taylor Lead Independent Director
Age: 67
Bio & Compensation  - Reuters